Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather A Behanna

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Chemical Communications (Cambridge, England)|September 30, 2005
Synthesis of stilbene carboxylic acids as scaffolds for calcium sensorsHeather A Behanna, Samuel I Stupp
Journal of the American Chemical Society|January 11, 2007
Modulation of fluorescence through coassembly of molecules in organic nanostructuresHeather A Behanna, Kanya Rajangam, Samuel I Stupp
Biochimica Et Biophysica Acta|September 26, 2006
Development of a novel bioavailable inhibitor of the calmodulin-regulated protein kinase MLCK: a lead compound that attenuates vascular leakHeather A Behanna, D Martin Watterson, Hantamalala Ralay Ranaivo
Journal of the American Chemical Society|January 27, 2005
Coassembly of amphiphiles with opposite peptide polarities into nanofibersHeather A Behanna, Jack J J M Donners, Alex C Gordon, et al.
Chemistry & Biology|October 26, 2005
Supramolecular fluorophores for biological studies: phenylene vinylene-amino acid amphiphilesDaniel A Harrington, Heather A Behanna, Gregory N Tew, et al.
Journal of Neuroimmunology|August 6, 2008
Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drugWilliam J Karpus, Nathaneal Reynolds, Heather A Behanna, et al.
International Review of Neurobiology|August 7, 2007
Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approachesLinda J Van Eldik, Wendy L Thompson, Hantamalala Ralay Ranaivo, et al.
Current Alzheimer Research|July 18, 2006
De novo and molecular target-independent discovery of orally bioavailable lead compounds for neurological disordersLaura K Wing, Heather A Behanna, Linda J Van Eldik, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 8, 2009
Molecular properties and CYP2D6 substrates: central nervous system therapeutics case study and pattern analysis of a substrate databaseLaura K Chico, Heather A Behanna, Wenhui Hu, et al.
Neuroscience Research|October 9, 2007
Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitisXiaoli Guo, Kazuaki Nakamura, Kuniko Kohyama, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Chemical Communications (Cambridge, England)|September 30, 2005
Synthesis of stilbene carboxylic acids as scaffolds for calcium sensorsHeather A Behanna, Samuel I Stupp
Journal of the American Chemical Society|January 11, 2007
Modulation of fluorescence through coassembly of molecules in organic nanostructuresHeather A Behanna, Kanya Rajangam, Samuel I Stupp
Biochimica Et Biophysica Acta|September 26, 2006
Development of a novel bioavailable inhibitor of the calmodulin-regulated protein kinase MLCK: a lead compound that attenuates vascular leakHeather A Behanna, D Martin Watterson, Hantamalala Ralay Ranaivo
Journal of the American Chemical Society|January 27, 2005
Coassembly of amphiphiles with opposite peptide polarities into nanofibersHeather A Behanna, Jack J J M Donners, Alex C Gordon, et al.
Chemistry & Biology|October 26, 2005
Supramolecular fluorophores for biological studies: phenylene vinylene-amino acid amphiphilesDaniel A Harrington, Heather A Behanna, Gregory N Tew, et al.
Journal of Neuroimmunology|August 6, 2008
Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drugWilliam J Karpus, Nathaneal Reynolds, Heather A Behanna, et al.
International Review of Neurobiology|August 7, 2007
Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approachesLinda J Van Eldik, Wendy L Thompson, Hantamalala Ralay Ranaivo, et al.
Current Alzheimer Research|July 18, 2006
De novo and molecular target-independent discovery of orally bioavailable lead compounds for neurological disordersLaura K Wing, Heather A Behanna, Linda J Van Eldik, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 8, 2009
Molecular properties and CYP2D6 substrates: central nervous system therapeutics case study and pattern analysis of a substrate databaseLaura K Chico, Heather A Behanna, Wenhui Hu, et al.
Neuroscience Research|October 9, 2007
Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitisXiaoli Guo, Kazuaki Nakamura, Kuniko Kohyama, et al.
Pageof 2